Cholera: Individualised risk assessment for travellers

+Summer Hiatus

In print

Practice + Travel medicine

Cholera: Individualised risk assessment for travellers

By Jenny Visser

Wednesday 1 January 2025, 12:30 PM

Cholera is considered a low-incidence disease in travellers, but the true impact is difficult to assess [Image: Erik Mclean on Unsplash]

We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!

This article was first published online on 31 July 2024.

This article summarises three papers about cholera, including the global situation, a new vaccine on its way, and guidelines on who should get vaccinated

This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.25 credits for continuing professional development purposes (1, Educate small, BACK panel - grey

Travel Medicine

Vaccines

Infectious Disease

Research

References

1. WHO. Multi-country outbreak of cholera. External Situation Report n. 15. 19 June 2024.

2. Levine MM, Chen WH, Kaper JB, et al. PaxVax CVD 103-HgR single-dose live oral cholera vaccine. Expert Rev Vaccines 2017;16(3):197–213.

3. López-Vélez R, Presotto D. Cholera in travellers: improving vaccination guidance in Europe. J Travel Med 2021;28(1):taaa209.

Summer Hiatus archive

How to Treat

+How to treat

Polypharmacy

For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews

Wednesday 28 May 2025, 12:50 AM